These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 20040698)

  • 1. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM; Wong M; Lightwood JM; Cheng CM
    Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to black box warnings for prescription medications in outpatients.
    Lasser KE; Seger DL; Yu DT; Karson AS; Fiskio JM; Seger AC; Shah NR; Gandhi TK; Rothschild JM; Bates DW
    Arch Intern Med; 2006 Feb; 166(3):338-44. PubMed ID: 16476875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of wording in "Dear doctor" letters and in black box labels.
    Weatherby LB; Nordstrom BL; Fife D; Walker AM
    Clin Pharmacol Ther; 2002 Dec; 72(6):735-42. PubMed ID: 12496755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescriber compliance with black box warnings in older adult patients.
    Ricci JR; Coulen C; Berger JE; Moore MC; McQueen A; Jan SA
    Am J Manag Care; 2009 Nov; 15(11):e103-8. PubMed ID: 19895180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Food and Drug Administration warnings on antidepressant use in a national sample.
    Olfson M; Marcus SC; Druss BG
    Arch Gen Psychiatry; 2008 Jan; 65(1):94-101. PubMed ID: 18180433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bringing greater transparency to "black box" warnings.
    Buckley NA; Rossi S
    Clin Toxicol (Phila); 2011 Jul; 49(6):448-51. PubMed ID: 21824055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Black box" 101: How the Food and Drug Administration evaluates, communicates, and manages drug benefit/risk.
    Murphy S; Roberts R
    J Allergy Clin Immunol; 2006 Jan; 117(1):34-9. PubMed ID: 16387581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical decision support tools: performance of personal digital assistant versus online drug information databases.
    Clauson KA; Polen HH; Marsh WA
    Pharmacotherapy; 2007 Dec; 27(12):1651-8. PubMed ID: 18041886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraindicated medications dispensed with cisapride: temporal trends in relation to the sending of 'Dear Doctor' letters.
    Weatherby LB; Walker AM; Fife D; Vervaet P; Klausner MA
    Pharmacoepidemiol Drug Saf; 2001 May; 10(3):211-8. PubMed ID: 11501334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical decision support tools: analysis of online drug information databases.
    Clauson KA; Marsh WA; Polen HH; Seamon MJ; Ortiz BI
    BMC Med Inform Decis Mak; 2007 Mar; 7():7. PubMed ID: 17346336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medicare Prescription Drug Plan Formulary Restrictions After Postmarket FDA Black Box Warnings.
    Solotke MT; Ross JS; Shah ND; Karaca-Mandic P; Dhruva SS
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1201-1217. PubMed ID: 31663461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Black box warnings in prescription drug labeling: results of a survey of 206 drugs.
    Beach JE; Faich GA; Bormel FG; Sasinowski FJ
    Food Drug Law J; 1998; 53(3):403-11. PubMed ID: 10346718
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA boxed warnings: how to prescribe drugs safely.
    O'Connor NR
    Am Fam Physician; 2010 Feb; 81(3):298-303. PubMed ID: 20112888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FDA drug prescribing warnings: is the black box half empty or half full?
    Wagner AK; Chan KA; Dashevsky I; Raebel MA; Andrade SE; Lafata JE; Davis RL; Gurwitz JH; Soumerai SB; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):369-86. PubMed ID: 16294363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of drug-interaction alerts in community pharmacies.
    Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
    J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Black box warnings: what do they mean to pharmacists and patients.
    Martin CM; Borgelt L
    Consult Pharm; 2012 Jul; 27(7):482-92. PubMed ID: 22910129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of droperidol before and after the Food and Drug Administration black box warning: a survey of the members of the Society of Ambulatory Anesthesia.
    Habib AS; Gan TJ
    J Clin Anesth; 2008 Feb; 20(1):35-9. PubMed ID: 18346607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.